phase readout
saveNCT04447027: Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
COMPLETEDupdated 14m ago
community read0 votes
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma, Relapsed/ Refractory T-cell Malignancies
view source ↗
comments(0)
5-min edit window · permanent after that